Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Mise à jour : Il y a 4 ans
Référence : NCT00290355

Femme et Homme

Extrait

Patients will receive injections of GSK 249553 vaccine . Appropriate tests will be performed to assess the safety of the treatment and its ability to induce an immune response.


Critère d'inclusion

  • Lung Cancer, Non-Small Cell


Liens